Description
CJC-1295 No DAC is a short-acting synthetic peptide analog of growth hormone–releasing hormone (GHRH). Unlike the DAC-modified version, this variant has a shorter half-life and is often investigated in laboratory settings for its pulsatile growth hormone release profile. Each batch is verified at ≥99% purity using HPLC UV analysis.
Research Highlights (from published studies):
-
Examined in preclinical models for growth hormone pulse stimulation
-
Studied in laboratory contexts of GH/IGF-1 signaling pathways
-
Investigated for effects on lipolysis and metabolic activity in experimental research
-
Reported to show distinct profiles compared to long-acting DAC versions
-
Frequently evaluated in stacked peptide research with GHRPs such as Ipamorelin
Examples of Research Contexts:
-
Laboratory studies of growth hormone and IGF-1 pathway regulation
-
Experimental research involving pulsatile versus sustained GH release
-
Preclinical investigations of peptide combinations in endocrine models
⚠️ Disclaimer: This material is intended for laboratory research use only. It is not approved for human consumption, medical use, or dietary supplementation. Peptara does not claim safety, efficacy, or therapeutic application in humans.